Phage display involves the expression of selected proteins on the surface of filamentous
phage through fusion with phage coat protein, with the genetic sequence packaged within, …

Although SARS-CoV-2-neutralizing antibodies are promising therapeutics against COVID-19,
little is known about their mechanism(s) of action or effective dosing windows. We report …

The emergence of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) led to
multiple drug repurposing clinical trials that have yielded largely uncertain outcomes. To …

Targeting model antigens (Ags) to Clec9A on DC has been shown to induce, not only cytotoxic
T cells, but also high levels of Ab. In fact, Ab responses against immunogenic Ag were …

Rapid development of diagnostic immunoassays against novel emerging or genetically
modified pathogens in an emergency situation is dependent on the timely isolation of specific …

Our understanding of the conformational and electrostatic determinants that underlie targeting
of human leukocyte antigens (HLA) by anti-HLA alloantibodies is principally based upon …

Nanomedicine-based and unmodified drug interventions to address COVID-19 have
evolved over the course of the pandemic as more information is gleaned and virus variants …

Identification of neutralizing antibodies with specificity away from the traditional mutation
prone antigenic regions, against the conserved regions of hemagglutinin from H5N1 influenza …

Serological testing of Singaporeans who received childhood smallpox vaccination found
anti-vaccinia IgG binding and neutralizing activity indicating long-term humoral immunity. There …

The monoclonal antibody VN04-2 was previously shown to protect mice against lethal A/Vietnam/1203/04
H5N1 virus challenge when administered pre- and post-infection. In this study, …